Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error page; its footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study record content, blocking access to trial details and related information.SummaryDifference19%

- Check34 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, representing a new release of the page. This may include minor updates or fixes to the page structure or metadata.SummaryDifference0.0%

- Check41 days agoChange DetectedA new revision stamp (Revision: v3.6.6) was added, replacing the previous v3.6.5. This indicates a small, internal update to the page's platform without altering study details.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded funding source information: '2018 ( U.S. NIH Grant/Contract )' appears under the study identifiers, clarifying NIH support for the trial. This provides context about who funded the study.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays revision v3.6.5, replacing v3.6.4. This indicates a minor backend/UI update to the page without modifying its content.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.